Australia and Oceania: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Australia and Oceania

The medicaments containing insulin market in Australia and Oceania skyrocketed to $X in 2021, with an increase of 27% against the previous year. Overall, consumption, however, recorded a relatively flat trend pattern. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in Australia and Oceania

In value terms, medicaments containing insulin production reduced to $X in 2021 estimated in export price. Over the period under review, production, however, saw a pronounced setback. The pace of growth was the most pronounced in 2020 with an increase of 3%. The level of production peaked at $X in 2012; however, from 2013 to 2021, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports in Australia and Oceania

In 2021, medicaments containing insulin exports in Australia and Oceania skyrocketed to X tons, picking up by 174% against 2020. Overall, exports saw a significant expansion. The pace of growth was the most pronounced in 2014 when exports increased by 210% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2016; however, from 2017 to 2021, the exports remained at a lower figure.

In value terms, medicaments containing insulin exports surged to $X in 2021. In general, exports recorded a strong increase. The pace of growth was the most pronounced in 2015 when exports increased by 179%. The level of export peaked at $X in 2016; however, from 2017 to 2021, the exports failed to regain momentum.

Exports by Country

Australia dominates exports structure, accounting for X tons, which was near 97% of total exports in 2021. New Zealand (X kg) followed a long way behind the leaders.

Australia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of +42.5% from 2012 to 2021. New Zealand (-12.3%) illustrated a downward trend over the same period. While the share of Australia (+97 p.p.) increased significantly in terms of the total exports from 2012-2021, the share of New Zealand (-96.6 p.p.) displayed negative dynamics.

In value terms, Australia ($X) remains the largest medicaments containing insulin supplier in Australia and Oceania, comprising 99% of total exports. The second position in the ranking was held by New Zealand ($X), with a 0.8% share of total exports.

From 2012 to 2021, the average annual growth rate of value in Australia totaled +42.1%.

Export Prices by Country

The export price in Australia and Oceania stood at $X per ton in 2021, shrinking by -20.8% against the previous year. In general, the export price recorded a drastic downturn. The most prominent rate of growth was recorded in 2019 an increase of 67% against the previous year. The level of export peaked at $X per ton in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Australia ($X per ton), while New Zealand stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Australia (-0.3%).

Medicaments Containing Insulin Imports

Imports in Australia and Oceania

In 2021, the amount of medicaments containing insulin but not antibiotics imported in Australia and Oceania soared to X tons, picking up by 77% compared with the previous year's figure. Over the period under review, imports, however, continue to indicate a relatively flat trend pattern. The volume of import peaked at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2021. In general, imports enjoyed a buoyant expansion. As a result, imports reached the peak and are likely to continue growth in the immediate term.

Imports by Country

The purchases of the six major importers of medicaments containing insulin but not antibiotics, namely New Caledonia, Australia, Samoa, Tonga, Fiji and Solomon Islands, represented more than two-thirds of total import. Vanuatu (X kg) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were recorded for Samoa (with a CAGR of +52.2%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, New Caledonia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Australia and Oceania, comprising 48% of total imports. The second position in the ranking was held by Australia ($X), with a 15% share of total imports. It was followed by Fiji, with a 12% share.

In New Caledonia, medicaments containing insulin imports expanded at an average annual rate of +8.2% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Australia (+51.5% per year) and Fiji (-0.1% per year).

Import Prices by Country

The import price in Australia and Oceania stood at $X per ton in 2021, picking up by 31% against the previous year. Import price indicated a prominent increase from 2012 to 2021: its price increased at an average annual rate of +9.0% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2014 an increase of 75%. Over the period under review, import prices reached the peak figure in 2021 and is likely to continue growth in the immediate term.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was New Caledonia ($X per ton), while Vanuatu ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Samoa (+32.3%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :